HPV Vaccine Rollout in India Faces Challenges
A study in Delhi found that only 42% of participants were aware of the HPV vaccine, and high costs posed a significant barrier, with only 20.8% willing to pay for it.
Experts emphasize the need for free access, education, and counseling to increase uptake and combat cervical cancer.
Greater public education and policy measures are necessary to improve accessibility and affordability of the vaccine.
As India prepares to add the HPV vaccine to the National Immunisation Schedule, addressing these challenges is crucial to ensuring broader acceptance of the vaccine.
Author's summary: India's HPV vaccine rollout faces awareness and cost barriers.
More News
- Hamilton urges Ferrari to make 'personnel changes' ahead of F1 2026
- Game Preview: Islanders vs Lightning
- Guadeloupean artist Kelly Sinnapah Mary wins French art prize at Art Basel Miami Beach
- Lando Norris wins his first F1 title despite Max Verstappen victory: Live updates and reaction
- Kelly Massol : « J’ai réalisé 40% de mon ambition »
- Lightning vs. Islanders Prediction, Odds, Picks - Dec. 6
- Pelicans' Questionable Offseason Trade Looks Better After Saddiq Bey's Rise
- Tampa Bay Lightning vs. New York Islanders - Game Highlights
- Spurs' Luke Kornet out Friday
- Kelly Osbourne — Instagram Snapshot